Clinical trial
Hyper- and Hypokalemic Periodic Paralysis Study
NCT00494507 · University of Rochester, Other · Completed
Key facts
| NCT number | NCT00494507 |
|---|---|
| Title | Hyper- and Hypokalemic Periodic Paralysis Study |
| Official title | Dichlorphenamide vs. Placebo for Periodic Paralysis |
| Acronym | HYP-HOP |
| Lead sponsor | University of Rochester, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hyperkalemic Periodic Paralysis, Hypokalemic Periodic Paralysis |
| Intervention type | Drug |
| Interventions | Dichlorphenamide (double-blind), Placebo (double-blind), Dichlorphenamide (open-label) |
| Enrollment | 71 |
| Start date | Jun 1, 2007 |
| Primary completion | Apr 1, 2013 |
| Completion | May 1, 2013 |
| First posted | Jun 29, 2007 |
| Last update posted | Jun 14, 2017 |
| Countries | Italy, United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: